Podcasts about Rosenberg

Assemblymember Chris Ward (D–San Diego) held a press conference Tuesday at the State Capitol to announce the introduction of AB 1542, new legislation to strengthen protections for sensitive personal data; continued efforts to advance AB 322, a two-year bill to ban the sale of geolocation data; and renewed momentum for AB 1337, a two-year bill currently pending in the Senate Judiciary Committee to modernize public-sector privacy protections. The press conference brought together consumer advocates, civil rights organizations, and privacy experts to underscore the urgency of protecting Californians' personal information from misuse, exploitation, and sale without consent. “Californians should not have to worry that their sensitive personal information is being sold to the highest bidder,” said Assemblymember Chris Ward. “From precise location data to deeply personal information, these bills work together to stop the sale of geolocation data, strengthen protections for sensitive information, and ensure government agencies are held to modern privacy standards. California led the nation on privacy once before, and we must continue to lead as technology evolves.” Justin Brookman, Director of Tech Policy at Consumer Reports, warned that data-driven pricing and monetization practices are outpacing existing protections. “People should not have to worry that their sensitive personal information is going to be sold to the highest bidder,” Brookman said. “The California Consumer Privacy Act was groundbreaking, but it needs to be updated to address the realities of the modern data ecosystem. Companies should use personal information like geolocation to deliver the services we ask for—not to secretly monetize it through data brokers.” Advocates emphasized the heightened risks these practices pose to vulnerable communities. “When businesses sell and trade sensitive personal information like precise location or immigration status, they open the door to surveillance, targeting, and exploitation. Those harms fall the hardest on the most vulnerable in our community, including immigrants, LGBTQ+ individuals, and survivors of domestic violence and human trafficking," said Lan Le, Policy Advocate at Asian Americans Advancing Justice Southern California (AJSOCAL). “These data privacy bills send a clear message: dignity and safety are rights, not commodities.” Supporters also highlighted the need to modernize how public agencies handle personal data. “In an era of increasing digital surveillance and data collection, it's crucial that our privacy laws evolve,” said Rindala “Rin” Alajaji, Associate Director of State Affairs at the Electronic Frontier Foundation. “AB 1337 is a much-needed update to ensure local governments are held accountable for how they handle personal data.” Tracy Rosenberg, Executive Director of Oakland Privacy, underscored how the measures work together. “The bill duo of AB 1337 and AB 322 attacks our current dystopia in two vital ways,” Rosenberg said. “They modernize privacy protections, add transparency and limits around precise location data, and curb invasive practices that expose Californians to government and industry overreach.” John Bennett, Initiative Director at CITED, emphasized the broader democratic stakes. “Privacy and freedom of movement are cornerstones of a healthy democracy,” Bennett said. “It's time to strengthen our data privacy laws and fulfill the promise of California's constitutional right to privacy—so people can move, assemble, and participate in civic life without fear of surveillance.” Ward's legislative package builds on California's landmark privacy framework to protect sensitive personal data, prohibit the sale of geolocation information, and ensure privacy rights keep pace with modern technology.

Send a textIn this conversation, Thomas' guest shares his inspiring journey from overcoming adversity to becoming a successful jiu-jitsu instructor and mentor. He emphasizes the importance of gratitude, health, and discipline in achieving personal growth. He also reflects on his journey to earning his black belt and the lessons learned along the way, culminating in the creation of the 1% Club, a program designed to help men become the best versions of themselves.Here is The RŌL Radio with a 3rd degree black belt, the owner of the YR Jiu-Jitsu Club, and the founder of the 1% Club, Yaniv Rosenberg.www.rolacademy.tv 30% discount with ROLRADIO code at checkout. Over 1600 videos for your Jiu-Jitsu journey.FREE Access to ROL TV - https://rolacademy.tv/yt/269-the-rol-radiohttp://www.therolradio.comhttps://www.instagram.com/therolradiohttps://www.facebook.com/therolradio/https://www.instagram.com/yanivrosenberg1/https://yrjiujitsu.com/?https://www.skool.com/yr1percentclub/aboutEpisode Highlights:2:09 Embracing Life and Living with Purpose11:31 Death Is Your Best Friend14:05 Discipline and Personal Growth28:30 Having Opportunities from Other's Sacrifice33:38 Money Isn't Everything39:05 Angel on One Shoulder Devil on the Other47:38 Yaniv's Jiu-Jitsu Beginnings1:00:20 Respect and Loyalty1:04:54 Yaniv's Black Belt DilemmaSupport the show

Guest BioMartin Rosenberg is the founder and CEO of OverseasInfo.tv, a pioneering video-based travel platform that connects travelers directly with tourism operators. With a background in international sales and procurement, Martin has spent decades building relationships across Europe and Asia. Originally from Glasgow, Scotland, he moved to London in 1985 before settling in Antalya, Türkiye, where he now balances semi-retirement with entrepreneurial passion.Known for his creative vision, sharp eye for detail, and love of networking, Martin continues to drive innovation in the travel space. His platform, OverseasInfo.tv, recently earned two industry awards for its unique approach to showcasing destinations through immersive video. When he's not developing new ideas, you can find him on the golf course enjoying the Mediterranean sun.Show SummaryIn this episode of the Big World Made Small Adventure Travel Podcast, host Jason Elkins speaks with Martin about his journey from international business executive to founder of an award-winning tourism platform. They explore how OverseasInfo.tv offers an alternative to major booking engines by promoting direct relationships between travelers and local operators through engaging video content.Martin shares insights into how technology — particularly AI — is reshaping customer service in the travel industry, and why authentic experiences matter more than ever. The episode takes listeners behind the scenes of the travel tech world, offering a glimpse into how personal passion and global insight can spark meaningful innovation.Key Takeaways✓ How Martin's global business background inspired a new approach to tourism✓ The story behind launching OverseasInfo.tv as a video-first platform✓ Why direct booking empowers both travelers and tour operators✓ The role of storytelling in building traveler trust✓ How AI is improving — and complicating — customer service in tourism✓ Challenges independent travel businesses face in a platform-dominated market✓ The importance of visual content in the discovery phase of travel planning✓ Why authenticity and human connection are key to meaningful travel✓ Martin's perspective on semi-retirement as a time for reinvention✓ How networking remains central to his success — both online and off Learn more about Big World Made Small Adventure Travel Marketing and join our private community to get episode updates, special access to our guests, and exclusive adventure travel offers on our website.

A Lecture Series by Rabbi Joseph B. Soloveitchik Lecture 6: Delivered February 5, 1959 Continuing with the idea of Judaism's glorification of the anonymous person, the Talmud says that the participants in the annual “kallah” Torah lectures receive divine reward not according to their intellectual achievements, but according to the amount of discomfort they put themselves through in order to participate. Thus, the diligent ignoramus could receive more reward than the accomplished scholar. Judaism stresses axiological democracy, the equal worth of the great scholar and the little person. Modern Man has yet to live up to this ideal of axiological democracy, and the biggest challenge of today's State of Israel is to live up to this ideal. The Talmud captures this axiological democracy in its dictum, “How do you know that your blood is redder than the blood of your neighbor?” Although Judaism's moral code recognizes the common right to dignity, such that we may not judge or embarrass anyone, it places special emphasis on the dignity on the humble and lowly person, with special injunctions against harming the deaf, blind, orphan, widow, and stranger. Rabban Gamliel the Prince, under the order of execution by the Romans, considered that perhaps he deserved his fate due to once making a widow feel unimportant. This sense of tenderness towards the downtrodden reflects God's own behavior and attitude towards the poor and oppressed, as described in Scripture. Peretz's story “Bontzye Shweig” illustrates this idea as well. This analysis leads to the problem of Jewish loneliness, which requires distinguishing between two different feelings, loneliness and aloneness. Loneliness comes from others inevitably rejecting one's message, one's kerygma. Aloneness comes from the numinous uniqueness inherent in each person. Loneliness brings with it destructive emotions, whereas aloneness is a creative and motivating force. Every person must suffer the loneliness of rejection at some point in life. Next lecture will discuss how Judaism tries to solve the problem of loneliness. Topics triggered by audience questions include the Rosenberg trial, historical controversies among Jews, establishment of a Sanhedrin in Israel, and standardized text for prayer. Jump to: 00:01:15 The Talmudic dictum that reward is granted according to effort 00:08:17 Axiological democracy in Judaism, modern society, and the State of Israel 00:26:24 The human right to dignity and the prohibition to embarrass people 00:44:27 Judaism's concern with the socially anonymous person 00:59:30 Imitatio Dei, imitating God, and the story of the death of “Bontzye Shweig” 01:26:29 Introduction to the problem of Jewish loneliness Access lecture summaries and course materials at www.TraditionOnline.org/JPM  The post A Jewish Philosophy of Man (E6): Judaism's Glorification of the Anonymous Person first appeared on Tradition Online.

In this episode of The Authority Company Podcast, Joe Pardavila sits down with Dr. Lawrence Rosenberg, one of Canada's leading healthcare CEOs and a practicing surgeon who rebuilt how hospitals think about leadership, systems, and patient care. Dr. Rosenberg breaks down why the healthcare system feels “broken” in both the U.S. and Canada, the real difference between complicated and complex problems, and why most medical training fails to prepare doctors to lead organizations. He shares how spending a full week living inside a hospital transformed his approach to accountability, patient flow, and executive decision-making. You also hear why courage matters in leadership, how data should drive every major choice, and why hiring and empowering the right people shapes culture more than policies ever will. If you lead a team, run an organization, or work inside complex systems, this conversation gives you practical insight into building clarity, accountability, and results at scale.

Send a textJeffrey Rosenberg, CFA, Managing Director is a senior portfolio manager within BlackRock Systematic. He leads active and factor investments for mutual funds, institutional portfolios and ETFs within BlackRock's Systematic Fixed Income (“SFI”) portfolio management team. In this role he serves as a member of the SFI Investment and Executive Committees and as a senior portfolio manager for several investment products including the BlackRock Systematic Multi-Strategy Fund (BIMBX), the iShares Systematic Alternatives Active ETF (IALT) and the iShares Managed Futures Active ETF (ISMF).We talked about systematic portfolio managers compared to discretionary portfolio managers, his career and education from finance and math into computational finance at Carnegie Mellon, the changes in the market from banks to hedge funds being driven by the global financial crisis, and some book recommendations.BlackRock Systematic Investing: https://www.blackrock.com/us/individual/investment-ideas/systematic-investingBlackRock's Q1 Fixed Income Outlook:https://www.blackrock.com/us/financial-professionals/literature/market-commentary/fixed-income-market-outlook.pdfJeffrey Roseberg:https://www.blackrock.com/us/individual/biographies/jeffrey-rosenbergJoin the quant community in Dallas, Texas April 10th at SMU!Quaint Quant Conference - 2026Learn and network from a close knit quant community!Support the show

Dr. Monty Pal and Dr. Ari Rosenberg discuss the evolution of treatment strategies in head and neck cancers, including the challenges of treating both HPV-positive and HPV-negative disease and the emergence of blood-based biomarkers to advance personalized therapy across different subtypes. TRANSCRIPT Dr. Monty Pal: Hello and welcome to the ASCO Daily News Podcast. I'm your host, Dr. Monty Pal. I'm a medical oncologist, professor, and vice chair of academic affairs at the City of Hope Comprehensive Cancer Center in Los Angeles. Today, we're going to explore the evolving landscape of treatment strategies in head and neck cancer management, including locoregionally advanced head and neck squamous cell carcinoma, which happens to be on the rise in United States, in part due to spike in HPV-mediated oropharyngeal cancers. We're also going to discuss the emerging strategies of using blood-based biomarkers to really advance personalized therapy. Joining me for this discussion is Dr. Ari Rosenberg. He's a medical oncologist focused on head and neck cancer, and he's an associate professor – congratulations on the recent promotion – at the University of Chicago. The University of Chicago has really produced luminaries in this field, Dr. Rosenberg included. I've had the pleasure of getting to know Dr. Ezra Cohen over the years, who really had his grounding there, and of course Everett Vokes, former ASCO President. I'm really looking forward to this conversation, Ari. Thanks so much for joining us. Dr. Ari Rosenberg: Thanks, Monty. Thanks for the invitation. Dr. Monty Pal: You got it. And just a quick note for our listeners, our full disclosures are going to be in the transcript at the end of this episode. So let's start with the basics, if you don't mind. So, head and neck cancers are very diverse and they're challenging, right? In the sense that they're near vital organs, the treatments, you know, as we all saw during fellowship, if not now in clinical practice. They can really have such a major impact on vital organ function, speech, swallowing, et cetera. Can you just comment on head and neck cancers that are on the rise in the U.S.? I alluded to this briefly. Particularly, we've heard this in the context of colorectal cancer and so forth. Are you actually seeing younger adults being affected by this? Dr. Ari Rosenberg: Yeah, thanks for that. The vast majority of head and neck cancers are head and neck squamous cell carcinomas, as I'm sure many of the listeners recall as well from fellowship or their current training. And as you alluded to, the organ function, long-term and functional quality of life outcomes are quite important, particularly in the context that these develop in high value real estate, parts of our head and neck area that we use for speaking, swallowing, all sorts of other essential functions as well. As you also alluded to, we think of this in two different particular subtypes of head and neck cancer. The historical head and neck cancer from 50, 60 years ago was almost exclusively related to carcinogen exposure, tobacco, alcohol use, and that subtype of carcinogen-induced head and neck cancer has been slowly declining. However, over the last now several decades, we've been seeing an increase in primary oropharyngeal squamous cell carcinoma, mostly tonsil, base of tongue. These are attributable to HPV, human papillomavirus exposure. And that's now the majority of the head and neck cancers that we tend to see in our clinic. As you also alluded to, these have very different prognoses as well. HPV-related head and neck cancer has a much more favorable prognosis where much of the interest has been in can we de-intensify to optimize long-term function? But then the non-HPV-related head and neck cancer, or what we call HPV-negative head and neck cancer, continue to be very, very challenging. We only managed to cure about half of these folks, with many of these patients developing the current disease. These patients, in addition to being difficult to treat, also have major impacts both in terms of the treatments they undergo as well as their disease that can impact their function and quality of life. And you hinted at this a little bit, but we have been seeing an increase in younger patients with HPV-negative head and neck cancer as well, which is quite concerning. Younger patients, oftentimes never smokers, never drinkers, who are developing non-HPV-negative head and neck cancer. And that's been a little bit of a more recent trend that we've been seeing as well. So, definitely a lot of work to be done to optimize and improve outcomes across all of these different head and neck cancer subtypes. Dr. Monty Pal: I mean, I'm just curious, you know, in the context of colorectal cancer, one of the things that we talk about is the potential role of the microbiome driving some of these young-onset cancers with, you know, perhaps there being an impact on, for instance, inflammation and the gut and what have you. Tell me about head and neck cancer. Is this anything known as to why younger patients might be getting diagnosed with non-HPV type cancers? It's odd to me. Dr. Ari Rosenberg: Yeah, it's a great question. A lot of people are working on it. I think we folks have hypotheses, but it hasn't totally panned out exactly what's going on there. It does have a little bit more of a tendency towards women, whereas historically head and neck cancer is much more common in men than it is in women. But lots of people working on that, whether it's related to chronic inflammation, whether it's related to the microbiome. Whether it's related to dental exposure, dental work. So, a lot of folks trying to parse that out because I agree with you, it needs to be identified alongside improving treatment paradigms for these patients, the young ones and the older patients as well. Dr. Monty Pal: Interesting, interesting. You know, one of the phenomena that was sort of coming around when I was in training 25 years ago was this role of sort of induction therapy for head and neck cancers. And of course, it's really come full circle now to include checkpoint inhibitors and so forth. Tell me a little bit about this and how you apply it, maybe in an HPV-mediated context, maybe in a non-HPV context. Dr. Ari Rosenberg: Yeah, absolutely. Induction chemotherapy, as you alluded to, or neoadjuvant chemotherapy, depending on what the locoregional treatment approach is. Similar to other cancer types where systemic control early on has many potential advantages in this setting. Now, in head and neck cancer, even though induction chemotherapy is quite active in head and neck cancer, both HPV-positive and HPV-negative with pretty good response rates. A survival advantage for all comers with local regionally advanced disease remains unproven. There's been two randomized trials, both underpowered, but essentially did not show a survival advantage, showing that induction chemotherapy for all patients with locoregionally advanced and neck cancer can't be justified for a survival advantage. That being said though, there remains a number of potential advantages of giving induction or neoadjuvant chemotherapy, of course, improving systemic control and debulking the disease early on has potential advantages, and predicting the responsiveness to subsequent radiation treatment. We know for some time in head and neck cancer that the percentage of shrinkage or the response to induction chemotherapy actually predicts outcome related to radiation as a dynamic biomarker where response can be used to select patients, for example, for de-escalated radiation has been an area of active investigation, active research. And it also remains a key opportunity to evaluate predictive biomarkers and understanding pre and post treatment to better understand the biology. I'll just add to your question that recently over this past year, we also saw phase 3 data for neoadjuvant immunotherapy for a subset of head and neck cancer that is surgically resectable. And so that's reintroducing the potential benefit in the immunotherapy era of incorporating immunotherapy in the neoadjuvant or the induction setting as part of the evolving treatment paradigm for these diseases. Dr. Monty Pal: That's really interesting. And you kind of alluded to already several topics that I plan to hit on, you know, for instance, the role of immune checkpoint inhibitors, induction, chemotherapy, and so forth. And you started to touch on biomarkers. And of course, I think that's something near and dear to many of us in academic oncology. One thing that we've started talking a lot about in the context of colorectal cancer is circulating tumor DNA. How do you think this might fit in the context of head and neck cancer? Can you give us a flavor for that? Dr. Ari Rosenberg: Yeah, absolutely. In head and neck cancer, the current landscape is most developed for circulating tumor DNA for HPV-related head and neck cancer. The advantage of HPV-related head neck cancer is that you have a distinctive HPV DNA that does tend to spill out into the peripheral blood and can be detected using various different blood-based assays. And because of that advantage as a tissue agnostic approach, it turns out that a number of HPV DNA plasma assays are actually quite sensitive and quite specific. And a number of them have indeed been commercialized. Of course, not only for detecting a baseline, but also grading responsiveness during treatment and probably most importantly in the post-treatment surveillance setting, the detection of HPV DNA in the plasma remains a very important and substantial predictor of developing recurrent disease. There's been a number of trials that have been emerging looking at ctDNA and HPV-related head and neck cancer, using it, for example, as a strategy to deescalate patients. That was something we saw this past ASCO from the Dana-Farber group, and also using it to early detect recurrence and potentially intervene earlier for patients with minimal residual disease positivity. So, that remains evolving and as many folks are, I think, already using it in the clinic. But ctDNA also has a lot of potential for HPV-negative head and neck cancer. This is actually a bit more challenging to develop because you don't have that HPV DNA that you can track predictably because the tumor is an HPV- negative disease are much more heterogeneous, but there are a number of data that are coming out both for personalized assays such as Signatera or some of the other assays that require tumor. Unlike colon cancer, which you referenced, where most patients get surgery upfront, in head and neck cancer, many of the patients receive non-surgical pre-chemoradiation. So sometimes the amount of tumor available to generate a personalized assay is more limited and can be one of the challenges that we see in head neck cancer. But certainly that also seems to be emerging. And there's also further assays that are being developed for HPV-negative head neck cancers, such as methylomic signatures and others that may be tissue informed or tissue agnostic. And these are also emerging, particularly in the post-treatment surveillance setting as strong predictors of recurrent disease. So while we're certainly behind some of these other more common tumor types, colon cancer, lung cancer, we're right there with them and more and more trials are going report out, including a number of trials in our upcoming [University of Chicago] Head and Neck Cancer Symposium where I'll be presenting some data and others in the field will be presenting some data looking at ctDNA both for HPV-positive and for HPV- negative to try to improve outcomes for these patients. Dr. Monty Pal: That's so interesting. I've got to tell you that in kidney cancer, what I deal with day to day is a very low shedding disease, right? So techniques as opposed to ctDNA looking for tumor-informed information, that might be less preferred to something like methylomics where you might not necessarily be so contingent on what's happening in the primary tumor. I'm really interested in you mentioning that. Just a point of clarification, this is something I'm trying to wrap my head around. You'd mentioned circulating tumor HPV DNA, right? I assume this is markedly different from just looking for HPV titers in the patient, right? So is this actually incorporated elements of HPV within, you know, essentially host genome, if you will? Dr. Ari Rosenberg: Yeah, correct. This is circulating tumor HPV DNA. And we think of it biologically as a plasma-based tumor DNA biomarker that's specific for HPV-related head and neck cancers. Dr. Monty Pal: Got it, got it. It makes me wonder whether or not this might be applicable to diseases like cervical cancer and so forth where there's also extensively, you know, biology driven by HPV. Is that fair? Dr. Ari Rosenberg: Yes, definitely. And in the head and neck cancer field, much of this ctDNA actually was derived from a different viral mediated head neck cancer, is less common in the U.S., but nasopharyngeal cancer, which is oftentimes associated with EBV. That has been a biomarker for quite some time in nasopharyngeal cancer. Of course, in places where EBV-associated nasopharyngeal cancer, is endemic, such as East Asia, this has been around for quite some time, but we've been using that in the U.S., and there's been trials that have used EBV DNA plasma to predict recurrence and stratify for adjuvant treatment, for example. And so now with HPV, it's much more applicable to our US population because the vast majority of our head and neck cancer patients that we see in the US that are viral mediated in the US tend to be HPV-related. So having assays that we can use to improve outcomes for that biological subset remains of particular interest for us. Dr. Monty Pal: Yeah, that's fascinating. By the way, for the fellows listening, there's tons of boards pearls here that Dr. Rosenberg shared, EBV-associated cancers, the role of HPV and treatment association. So if you're recertifying anytime soon, I definitely think there's notes to take from this conversation indeed. I wanted to shift gears a little bit. And obviously, you're a prolific researcher. I don't think anyone goes through their fellowship in medical oncology without recounting these experiences of our head and neck patients really suffering from treatment-related toxicities. It's a real challenge. And I'm just wondering, I know a big body of work that you're focused on is really using multimodality treatment paradigms to perhaps reduce the cumulative treatment burden of patients with head and neck cancers. Can you talk about that a little bit? Dr. Ari Rosenberg: Yeah, definitely. Thanks for the question. And before I start going into some of the strategies, I'll just say that head and neck cancer, this is particularly for the fellows that are listening as well, just in reference to your prior comment, that this is really a multidisciplinary disease. At our center, all head and neck cancer patients are seen upfront at that first visit by all three specialties, med onc, rad onc, and surgery, because the choice and sequencing of modalities to optimize not only survival, but also functional quality of life outcome is so critical. And I think that's probably the biggest takeaway for anyone who treats a lot of head and neck cancer or will be treating a lot of head and neck cancer in the clinic. But in terms of more specific attempts at trying to optimize some of those parameters that you described, we really think about these separately in terms of HPV-positive and HPV-negative head and neck cancer. For HPV-positive head and neck cancer, the cure rates are quite high with chemo radiation, although not for everyone. There's still about 15, 10 to 15 % of folks that will develop a recurrence. But for the vast majority of patients, standard chemoradiation is quite a cure to therapy, but the toxicity associated with that can be quite substantial. And so there's been a number of attempts to try to deescalate treatment. It turns out that deescalating everyone with locoregionally advanced HPV-positive head and neck cancer is not a good strategy because it's not able to select out the patients that really do need full dose treatment. And we have seen some negative trials that show inferior outcomes when everyone is deescalated. But what does remain promising is again, trying to select out who the best candidates are for deescalated treatment. The folks at MSK have hypoxia imaging that they're using in trials that looks quite promising to select for the more favorable deescalatable biology. At our center, we've been interested in using induction chemotherapy to stratify response and select patients for deescalated treatment with excellent survival outcomes and reduce toxicity with deescalated treatment. And more recently, ctDNA that us and other groups, such as the Dana-Farber group, is using. And that also looks quite promising. Again, how do you select the patient who will do well with less radiation versus the ones that really need the full doses and volumes of radiation? And then for HPV-negative head and neck cancer, this is a much trickier disease because already the survival outcomes are not like we want it to be. Trying to figure out how to improve survival outcomes remains an important thing. Using immunotherapy seems to be one of the key cornerstones to that. But these are patients that also suffer from a lot of toxicity related to their treatment. We completed a trial not too long ago that we published this past year where we, in HPV-negative head and neck cancer patients, de-intensified the radiation for responders to neoadjuvant chemoimmunotherapy. And those patients did similar, if not even a little bit better, than the non-responders who got full dose treatment. So something that does warrant further investigation as well. How do we not only improve survival for those patients, but also reduce some of the long-term toxicities? Dr. Monty Pal: This is brilliant. I'm taking so many notes as you were mentioning these items. There are so many areas where I think the research crosses over. I already mentioned, know, ctDNA, for instance, and metabolomics and the places where that might apply to kidney cancer. The hypoxia imaging really caught my ear too. Obviously, kidney cancer is disease highly predicated on hypoxia. So thank you for all of this. We've got about a minute or so. So, I'm going to ask you for a really tall task here. Can you tell us what you foresee being some of the biggest challenges that sort of lie ahead and head and neck cancer. You've already kind of alluded to it with ongoing research, but if you had to pick maybe 2, 3 problems, the very most that we really need to get to and head and neck cancer, what would that be? Dr. Ari Rosenberg: Yeah, that's a great question. Obviously, lots of things to be done, but if I'm going to limit it to just a couple, I would say number one is really trying to improve the survival for HPV negative local regionally advanced head and neck cancer. We talked early on about how we are seeing, you know, of course we see many of these people that were smokers and drinkers, but also seeing these in younger patients, in patients without a history of tobacco use. Some of these are very biologically aggressive and we need better treatments beyond surgery, beyond chemo radiation, beyond immunotherapy to improve outcomes for these patients and cure more of them. So, I would say that's one big area. And the other is, which we didn't speak about so much in this talk, but remains one of the biggest challenges that we see in the clinic is the recurrent metastatic head and neck cancer patients. This is an incredibly challenging disease to treat, not only with poor survival, but also with substantial impacts on quality of life and function. mean, these are bad recurrences that cause a lot of pain, functional deficits, really impacts quality of life as well. So developing novel therapies, many of which are currently in clinical trials and many of which are currently continuing to be developed, remains so critical. How do we develop better systemic therapies, better targeted therapies, better biomarkers for recurrent metastatic head neck cancer to improve their survival and quality of life and functional outcomes. Those are the two big areas that require the most work at this time within the head and neck cancer field. Dr. Monty Pal: That's brilliant. I mean, I have to tell you I could probably talk to you all day about this, such a fascinating topic. It's a very exciting time in the field. Thank you, Dr. Rosenberg, for all your incredible contributions and thanks for sharing with us your insights on the ASCO Daily News Podcast. Dr. Ari Rosenberg: Yeah, and thanks for the introduction. Hope to do it again soon. Dr. Monty Pal: And many thanks to our listeners for your time today. If you value the insights that you hear from the ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. More on today's speakers:      Dr. Monty Pal   @montypal  Dr. Ari Rosenberg @AriRosenbergMD Follow ASCO on social media:           ASCO on X     ASCO on Bluesky          ASCO on Facebook           ASCO on LinkedIn           Disclosures:        Dr. Monty Pal:       Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview      Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical      Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis  Dr. Ari Rosenberg:     Stock and Other Ownership Interests: Privo Technologies Consulting or Advisory Role: Nanobiotix, EMD Serono, Vaccitech, Novartis, Eisai, Astellas Pharma, Regeneron, RAPT Therapeutics, Geovax Labs, Janssen, Summit Therapeutics Speakers' Bureau: Coherus Biosciences Research Funding (Inst.): Hookipa Biotech, EMD Serono, Purple Biotech, Bristol-Myers Squibb/Celgene, BeiGene, Abbvie, Astellas Pharma, Pfizer, Janux Therapeutics

Howard Rosenberg had done what many of us were taught to do. He got an education, built a career, and provided for his family. From the outside, it checked every box.   But in his early fifties, a diagnosis of advanced heart disease and emergency quintuple bypass surgery forced him to slow down and take a hard look at the life he had built.   That wake-up call led Howard to begin asking deeper questions about identity, purpose, creativity… and what really sustains us in the second half of life.   We talked about: How a health wake-up call led to a complete identity shift Why the way we finish the sentence "I am…" matters The difference between external success and internal fulfillment How creativity extends far beyond art What it really means to consciously create your next chapter   Resources Howard Rosenberg's Life Coaching Howard on LinkedIn  

Fra Wonderful World 2025 • Göran Rosenberg, Jan Inge Reilstad • I 2024 inviterte vi Göran Rosenberg til KÅKÅnomics. På en tur til Prekestolen fortalte han andpusten at han holdt på med en bok om mysteriet verden, om undringen over at vi mennesker og virkeligheten faktisk fins. Arbeidstittelen var «A Wondrous World». Den aller første avtalen om deltagelse på Wonderful World 2025 ble gjort der og da på Prekestolen. Vi bestilte sporenstreks selve åpningsforedraget fra Göran, som også takket ja til å sitte i festivalens redaksjonsråd som vårt svenske alibi. Göran Rosenberg er en av Sveriges skarpeste penner og viktigste offentlige personer, med bakgrunn innen journalistikk, TV og med et omfattende forfatterskap bak seg; om sin jødiske herkomst, om Israel, om USA, om journalistikk, om det svenske folkhemmet - og om kunsten å være menneske.  

A Note from Michael: The Thriving Farmer Podcast is currently on pause as we navigate a busy season on the farm. While we're taking this break, we're excited to share Farm in Focus, a special series of short, focused conversations recorded earlier this year. These bite-sized episodes highlight practical insights from farmers and experts across the industry. We hope they're helpful and encouraging as you continue your farming journey. How can technology help farmers save labor, increase efficiency, and monitor their farms in real time? In this Farm in Focus episode, Michael is joined by Nathan Rosenberg, CEO and co-founder of FarmBlox, to explore the biggest trends shaping farm technology today. From robotics to sensors to drones, Nathan breaks down which innovations truly move the needle — and which ones are more hype than help. Nathan explains why labor-saving tools are the top priority for most farms today, how sensors can automate tasks like monitoring maple syrup sap runs, and why theft prevention is becoming a critical need in orchards and high-value crop production. He also shares practical advice for farmers interested in adopting new technology without getting overwhelmed or oversold. Whether you're curious about automation or just want smarter ways to solve farm pain points, this conversation will help you understand what's worth paying attention to — and what to ignore.   In this episode, you'll hear about: Farm Tech Trends: • Why labor is the biggest cost driving innovation [1:53] • Where robotics and remote sensing are making the biggest impact [04:10] Real-World Applications: • How sensors can automate maple syrup production and orchard monitoring [04:32] • Why theft prevention is becoming a major tech need in agriculture [07:20] Drones & Data: • What drones can (and can't) do for farmers [09:55] • Using real-time monitoring to catch issues early [10:50] Practical Advice for Farmers: • Why "start small" is the smartest approach to adopting new tech • How to identify the pain points worth solving before investing About the Guest: Nathan Rosenberg is the CEO and Co-Founder of FarmBlox, a platform that gives farmers tools to build their own automation systems — connecting sensors, equipment, and real-time data to a simple app. With a background in robotics engineering and over a decade of experience building large-scale IoT networks, Nathan brings a deep understanding of how automation, AI, and practical engineering intersect on real farms. Links:

Hour 3: Tommy opens up the melting pot of sports in the 3rd hour of the show. Tyson vs. Mayweather, Logan Paul's big card sale, Rosenberg's Loopy and much more are discussed!

Joab Rosenberg, partner at Deep33, a new $100–150M venture fund focused on the future of compute, is interviewed by Yuval Boger. They discuss the current state of quantum computing, why Joab expects commercial applications within a few years, and where venture capital can realistically capture value. The conversation covers hardware-first investing, quantum algorithms and applications, capital intensity, geopolitics, and the growing role of deep tech in venture investing.

Fatigue, joint pain, brain fog, hair loss, anxiety… and your doctor says your labs are fine. What if your breast implants are the missing piece? In this episode, I join Brandi to explore the truth about Breast Implant Illness (BII) and share essential information to help you understand what to do about this growing health concern. What We Cover:What breast implant illness (BII) actually is and why it's not "in your head"The top reported symptoms of BII to look out for How breast implants increase your risk of autoimmune diseasesMechanisms of breast implant illness like the biofilm theoryThe "rain barrel effect": how long-term immune dysregulation leads to gut issues, nutrient deficiencies, and toxic overloadTimeline of symptom onset with BIIHow to safely remove implantsWhy explant is just the beginning and the next steps to true healingSponsors:EQUIP Prime Protein: https://www.equipfoods.com/NHR15 Save 15% off with code: NHR15Connect with Rachel:Free Health Consultation with Rachel: ⁠⁠⁠⁠⁠⁠⁠https://www.naturalhealthrising.net/health-consultation⁠⁠⁠⁠⁠⁠⁠Free Webinar to Heal Your Autoimmune & Mystery Symptoms: ⁠⁠⁠⁠⁠⁠⁠https://www.naturalhealthrising.net/webinar⁠⁠⁠⁠⁠⁠⁠Join the Natural Health Rising community to heal naturally: ⁠https://www.skool.com/natural-health-rising-6209/about?ref=77c29ce69cbf4fb2be0865f18fea6bcc⁠Website: ⁠⁠⁠⁠⁠⁠⁠https://naturalhealthrising.com/⁠⁠⁠⁠⁠⁠⁠Support this podcast: ⁠⁠⁠⁠⁠⁠⁠https://anchor.fm/rachel-smith11/support⁠⁠⁠⁠Breast Explant References:[1] Ferreira, S., Barros, A. S., & Marques, M. (2025). Breast Implant Illness: Symptoms, Outcomes with Explantation and Potential Etiologies—A Systematic Review and Meta-analysis. Aesthetic Plastic Surgery, 49(23), 6600–6620.[2] U.S. Food and Drug Administration. (2025, February 6). Medical Device Reports of Systemic Symptoms in Women with Breast Implants.[3] Suh, L. J., Khan, I., Kelley-Patteson, C., Mohan, G., Hassanein, A. H., & Sinha, M. (2022). Breast Implant-Associated Immunological Disorders. Journal of Immunology Research, 2022, 8536149.[4] Watad, A., Rosenberg, V., Tiosano, S., et al. (2018). Silicone breast implants and the risk of autoimmune/rheumatic disorders: a real-world analysis. International Journal of Epidemiology, 47(6), 1846-1854.[5] Adams, W. P., Jr., & Deva, A. K. (2020). Surgical Best Practices: 14-Point Plan. Sientra.[6] DeCesaris, L. (2022, September 22). A Functional Medicine Approach to Breast Implant Illness: BII. Rupa Health.[7] Dreyfuss, D. (n.d.). 8 Tips for a Quick Breast Implant Removal Recovery. Dreyfuss Plastic Surgery.

Law firms are quietly rewriting the rules on growth power and ownership as consolidation, private capital and talent pressure push the industry toward a fundamentally different future. Chris Batz and Howard Rosenberg step back from deal headlines to talk about what 2025 revealed beneath the surface of the legal market. Mergers are no longer driven by geography alone and private capital is no longer a fringe topic whispered about behind closed doors. The conversation centers on how managing partners are being forced to rethink scale strategy and long-term value in an environment where standing still is no longer an option. The episode also unpacks why enterprise value has entered the law firm vocabulary and why partners are beginning to question a model that pays well annually yet offers little on the way out. With investors circling smaller and mid-sized firms first, Chris and Howard explore what private capital really wants from law firms and what law firms may gain or risk by engaging it. Is this about cashing out or about building something durable that attracts talent and creates optionality over time? Looking ahead to 2026, the discussion widens to include boutique firms, venture-backed legal platforms and a talent market that no longer respects seasonality. New firms will launch. Others will combine. Some will struggle to adapt. The episode leaves listeners with a clear takeaway. The legal industry is no longer debating whether change is coming. The real question is who is preparing for it with intention and who is hoping yesterday's rules still apply.   Episode Breakdown: 00:00 Reflecting on 2025: A Year of Change 03:11 Mergers and Acquisitions: The New Landscape 10:30 Private Capital: A Game Changer for Law Firms 18:27 The Future of Law Firms: Trends and Predictions 25:52 Innovations in Legal Services: The Rise of Tech Companies   Connect with Howard Rosenberg: Connect with Howard on LinkedIn Howard's Company Web Profile   Connect with Chris Batz: Connect with Chris on LinkedIn  Follow Columbus Street on LinkedIn Columbus Street Website  MergerWatch Website   Podcast production and show notes provided by HiveCast.fm  

Lynne Marie Rosenberg joins Angela to talk about content creation, teaching, and etymology. Lynne shares her journey from acting and activism into applying for a Fulbright Scholarships and collaborating in Ireland. To find out more about Lynne, visit her website and insta.

Joe Piscopo and John Catsimatidis interview Sid Rosenberg, a prominent broadcaster who reflects on his professional evolution from sports journalism to news and politics. The conversation highlights the tight-knit "family" atmosphere of the station, touching on Rosenberg's upcoming television appearances and his acting roles in the series Gravesend. A significant portion of the dialogue focuses on Rosenberg's personal relationship with Donald Trump, including his appointment to the Holocaust Museum board and his direct communication with the former president. Learn more about your ad choices. Visit megaphone.fm/adchoices

TODAY ON THE ROBERT SCOTT BELL SHOW: DOJ Probes Religious Exemptions, RFK Vaccine Freedom Choice, Kim Mack Rosenberg, AAP Lawsuit, Political Divide Deepens, Trump Signs Pandemic Bill, FDA Autism Page Removed, Ultra processed Food and Cigarettes, Costco Chicken Labels, Abies Canadensis - Pinus Canadensis, and MORE! https://robertscottbell.com/congress-demands-doj-probe-kennedys-vaccine-freedom-choice-kim-mack-rosenberg-political-divide-deepens-trump-signs-pandemic-bill-fda-autism-page-removed-food-or-cigarettes-costco-chicken-lab/ Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.

Michelle Knudsen, celebrated author of over fifty children's books (and a personal favorite) agreed to interview Mel Rosenberg on the eve of publication of the North American version of Emily Saw A Door (Orit Magia, illustrator, Random House Studio, Feb. 24th, 2026), Mel's debut picture book overseas. We talk about how Emily Saw A Door came to be, the author's journey and process. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Michelle Knudsen, celebrated author of over fifty children's books (and a personal favorite) agreed to interview Mel Rosenberg on the eve of publication of the North American version of Emily Saw A Door (Orit Magia, illustrator, Random House Studio, Feb. 24th, 2026), Mel's debut picture book overseas. We talk about how Emily Saw A Door came to be, the author's journey and process. Learn more about your ad choices. Visit megaphone.fm/adchoices

CM Punk finally gets his WrestleMania moment, headlining Night 2 against Roman Reigns in a main event that delivers everything Punk fans have been waiting for. Rosenberg and SGG break down what this match means for Punk's legacy and the potential impact on WWE moving forward. Plus, could AJ Styles wrestle elsewhere, or is the Phenomenal One truly retired? Listen to Cheap Heat Live Fridays 12pm- 2pm EST on Pro Wrestling Nation 24/7 on Channel 156.Call in at 844-344-4893Wanna stay MAJ?Join our PateronFollow @cheapheatpod on Instagram and TikTok @cheapheatpod Hosted on Acast. See acast.com/privacy for more information.

In this eye-opening episode of Our Hen House, Jasmin Singer and Mariann Sullivan speak with Jan Dutkiewicz and Gabriel Rosenberg about their groundbreaking new book, Feed the People: Why Industrial Food Is Good and How to Make It Even Better. The authors present compelling evidence that our food system myths are preventing real progress, particularly when it comes to animal agriculture,…

Sid's mom, Naomi, calls into the show to offer a mother's perspective on the missing persons case involving news anchor Savannah Guthrie's mother, Nancy Guthrie. Learn more about your ad choices. Visit megaphone.fm/adchoices

Birgit Rosenberg, Sportchefin des CHIO Aachen, nimmt uns mit hinter die Kulissen der Weltmeisterschaft 2026 in Aachen. Wir sprechen darüber, warum die WM nicht einfach „ein CHIO in größer“ wird, was organisatorisch komplett neu gedacht werden muss – und welche Highlights uns in zwei intensiven Wochen erwarten. Besonders spannend für uns Vielseitigkeitsmenschen: Aachen baut fürs Championat um – inklusive langem Format in der Vielseitigkeit mit erweiterter Strecke, neuen Loops und vielen Alternativen für Sicherheit und Fairness. Außerdem geht's um neue Stallungen, internationale Volunteers, Ticketing (Spoiler: teils schon knapp) und warum Transparenz & Pferdewohl bei der WM eine große Rolle spielen.

How can you make experiential learning not just something your college does but part of who you are? As you move from doing it ad hoc to integrating at scale, how can you overcome resistance to change? What's the right mix of communications, incentives, and training? On a special 100th episode, we dive into these questions with Brian Rosenberg, author of "Whatever It Is, I'm Against It", Visiting Professor at Harvard Graduate School of Education, and former President of Macalester College.

Veteran economist David Rosenberg delivers a sobering diagnosis of market euphoria, warning of parabolic excess and a looming reality check. Rosenberg frames the frenzied energy at the Vancouver conference as a dangerous sign, noting it feels like “a tech conference back in 1999.”He points to silver's wild surge and gold's relentless climb past his own targets as signals of an overheated market, stating, “When anything goes up, vertical, completely vertical, like asymptotically north, you got to be wondering what's going on… These are not normal moves.” He also argues that the era of easy gains is facing a sharp correction, drawing a stark lesson from history: “Successful investing… is you play the middle 60% of the cycle. You don't try and time the lows or the peaks… I've never met anybody that can do it.” Watch the video to hear his perspective on the U.S. dollar, the S&P, and the outlook for the metals market. ✅ FREE RESOURCESDownload The Private Wealth Playbook — a data-backed guide to strategically acquiring gold and silver for maximum protection, privacy, and performance. Plus, get Daniela Cambone's Top 10 Lessons to safeguard your wealth (FREE)

Ahead of the Royal Rumble in Riyadh, Rosenberg sits down with Je'Von Evans, who is hyped about competing in his first-ever Royal Rumble. Rosenberg then catches up with Kofi Kingston and Xavier Woods as The New Day look back on everything from the split with Big E to KofiMania, losing the WWE Championship to Brock Lesnar, and what it means to be long-tenured WWE superstars.Listen to Cheap Heat Live Fridays 12pm- 2pm EST on Pro Wrestling Nation 24/7 on Channel 156.Call in at 844-344-4893Wanna stay MAJ?Join our PateronFollow @cheapheatpod on Instagram and TikTok @cheapheatpod Hosted on Acast. See acast.com/privacy for more information.

Arms Rosenberg from Minotaur Capital Management joins us to recap the markets today. See omnystudio.com/listener for privacy information.

Hour 3: Tommy talks about the possibility of Odell Beckham Jr to the Giants and the topic of desserts with Rosenberg.

Hour 1: Tommy talks Sam Darnold, the Jets and next week's Westminster Dog Show with Rosenberg.

*Content Warning: institutional betrayal, sexual violence, stalking, on-campus violence, intimate partner violence, gender-based violence, stalking, rape, and sexual assault.Free + Confidential Resources + Safety Tips: somethingwaswrong.com/resources   Follow Dr. Nicole Bedera: Website: https://www.nicolebedera.com/  Blue Sky: https://bsky.app/profile/nbedera.bsky.social  Book: On The Wrong Side - How Universities Protect Perpetrators and Betray Survivors of Sexual Violence: https://www.nicolebedera.com/about-1  SWW Sticker Shop!: https://brokencyclemedia.com/sticker-shop SWW S25 Theme Song & Artwork: The S25 cover art is by the Amazing Sara Stewart instagram.com/okaynotgreat/ The S25 theme song is a cover of Glad Rag's U Think U from their album Wonder Under, performed by the incredible Abayomi instagram.com/Abayomithesinger. The S25 theme song cover was produced by Janice “JP” Pacheco instagram.com/jtooswavy/ at The Grill Studios in Emeryville, CA instagram.com/thegrillstudios/ Follow Something Was Wrong: Website: somethingwaswrong.com  IG: instagram.com/somethingwaswrongpodcast TikTok: tiktok.com/@somethingwaswrongpodcast  Follow Tiffany Reese: Website: tiffanyreese.me  IG: instagram.com/lookieboo Sources:Bedera, N. (2021). Beyond Trigger Warnings: A Survivor-Centered Approach to Teaching on Sexual Violence and Avoiding Institutional Betrayal. Teaching Sociology, 49(3), 267-277. https://doi.org/10.1177/0092055X211022471  Bedera, Nicole (2022). "The illusion of choice: Organizational dependency and the neutralization of university sexual assault complaints." Law & Policy 44(3): 208-229. https://deepblue.lib.umich.edu/items/4ded7343-efe3-499f-a61a-3a1bf03258e3Bedera, Nicole. 2024. “I Can Protect His Future, but She Can't Be Helped: Himpathy and Hysteria in Administrator Rationalizations of Institutional Betrayal.” The Journal of Higher Education 95 (1): 30–53. doi:10.1080/00221546.2023.2195771. Bedera, Nicole et al. “"I Could Never Tell My Parents": Barriers to Queer Women's College Sexual Assault Disclosure to Family Members.” Violence against women vol. 29,5 (2023): 800-816. doi:10.1177/10778012221101920 https://pubmed.ncbi.nlm.nih.gov/35938472/ Bedera, Nicole Krystine. On the Wrong Side: How Universities Protect Perpetrators and Betray Survivors of Sexual Violence. University of California Press, 2024. https://www.nicolebedera.com/about-1 Cipriano, A. E., Holland, K. J., Bedera, N., Eagan, S. R., & Diede, A. S. (2022). Severe and pervasive? Consequences of sexual harassment for graduate students and their Title IX report outcomes. Feminist Criminology, 17(3), 343–367. https://doi.org/10.1177/15570851211062579 Grassi, Margherita, and Eleonora Volta. “Controlling the Narrative: The Epistemology of Himpathy in Sexual a...” Phenomenology and Mind, Rosenberg & Sellier, 1 Dec. 2024, journals.openedition.org/phenomenology/4128

Welcome to The Hangar Z Podcast, brought to you by Vertical HeliCASTS, in partnership with Vertical Valor Magazine.This episode was recorded on location in Cologne, Germany, at European Rotors.In this episode, host Jon Gray sits down with Daniel Rosenberg from the Swedish National Police.Rosenberg is a remarkable guest whose journey in law enforcement has taken him from patrolling the streets of Sweden, to playing a pivotal role in the Air Support Unit. With over a decade of experience, including work on a surveillance team combating organized crime and serving with the Swedish Security and Intelligence Service, he has gained unique insights into the importance of intelligence in policing. Since joining the Air Support Unit in 2018 as a tactical flight officer, he has focused on training and developing mission equipment and tactics. Today, we'll explore how he's leveraging advanced systems to visualize information, enhancing proactive responses in critical situations. We also talk about the integration of drone technology in policing and the evolving landscape of law enforcement operations. Join us as we explore his innovative approaches and the future of air support in law enforcement.Thank you to our sponsors Airbus, Anodyne Electronics Manufacturing and Robinson Helicopter.

With SGG and Dip off on side quests this week, Rosenberg not Rosenblum (yes, Alvarez, we see you) goes solo to break down the biggest questions coming out of WWE right now. When and if fans will ultimately get CM Punk vs. Cody Rhodes, whether the lack of genuine surprises in the Royal Rumble is becoming a concern, and if Gunther should retire AJ Styles and whether that's the right move are all on the table. Hosted on Acast. See acast.com/privacy for more information.

Dan Nathan and Guy Adami are joined by David Rosenberg, founder and president of Rosenberg Research. The discussion covers Rosenberg's past market predictions, his outlook for 2025-2026, and his insights on various economic themes. Rosenberg reflects on his bearish stance on US equities and bullish view on long-term treasuries, analyzing key trends like inflation, the impact of tariffs, and the strength of the US dollar. The conversation also touches on the influence of AI-related investments in the market, the economic implications of stock market performance, and the potential for recession given current employment and income data. Rosenberg emphasizes the importance of understanding market cycles and the significant role of investor behavior. The episode concludes with his views on gold prices, central bank policies, and possible future economic scenarios. —FOLLOW USYouTube: @RiskReversalMediaInstagram: @riskreversalmediaTwitter: @RiskReversalLinkedIn: RiskReversal Media

Join us as we explore the transformative journey of Nicole Rosenberg, the founder of Wanderful Abroad, who shares her unique insights into moving overseas and personal evolution. Through Nicole's personal story of transitioning from a brand ambassador and side-hustler to a relocation expert, we learn about the crucial role of intuition and "identity shifting" in successfully starting a new life in countries like Thailand, South Korea, Mexico, and Spain. Nicole offers valuable perspectives on how prioritizing connection with local cultures and learning new languages can resolve the stagnation of a "US-centric mindset" and foster deeper global empathy. Listen in as we discuss the complexities and triumphs of moving abroad during a pandemic and uncover how understanding your own personality traits can lead to finding the perfect international destination. In our engaging conversation, we also address the significance of financial preparation and emotional resilience in the relocation process. Nicole shares her observations from her travels and coaching experiences, highlighting the benefits of strict budgeting rituals and side-hustle momentum in creating a feasible path to moving abroad. We discuss the challenges faced by those "stuck in the mud" of indecision and the importance of tapping into one's instincts during major life transitions. Nicole introduces her personalized coaching programs, offering practical advice for navigating visas, finding remote work, and managing the "identity layers" that come with living in a foreign land. Discover transformative resources through Nicole's social media platforms and explore her 30-minute introductory calls for further engagement with her innovative "Wanderful Abroad" programs. Connect with Nicole:Website: www.wanderfulabroad.net LinkedIn: Nicole Rosenberg Instagram: @wanderful_abroad1023_ TikTok: wanderfulabroad1023 Let's keep the conversation going!Website: www.martaspirk.com Instagram: @martaspirk Facebook: Marta Spirk Want to be my next guest on The Empowered Woman Podcast?Apply here: www.martaspirk.com/podcastguest  Watch my TEDx talk: www.martaspirk.com/keynoteconcerts      There's a reason Pitch Worthy is on every power founder's radar. It's the definitive PR book for women done with being overlooked. If you're ready for press, premium clients, and undeniable authority, this is your playbook. Buy your copy now at hearsayPR.com.  

Ursodiol (ursodeoxycholic acid) is a prescription bile acid medication used to dissolve cholesterol gallstones, prevent gallstones during rapid weight loss, and treat liver diseases like primary biliary cholangitis (PBC) by reducing toxic bile acids and cholesterol production. It works by changing bile composition, making it less saturated with cholesterol, and is available as oral medication. Of course, it is also the foundational medication for treatment of diagnosed Intrahepatic Cholestasis of Pregnancy (ICP). Does this medication reduce adverse perinatal outcomes? In this episode, we will review a new study from the Green Journal, which will be out in February 2026, examining the recurrence risk for ICP using data from NY. In a patient with prior history of ICP, is there any guidance on monitoring of serum bile acids in the subsequent pregnancy before symptoms develop? We will explain. PLUS we will review the data on whether Ursodiol may hold promise in recurrence prevention or in reduction of adverse outcomes once the condition is diagnosed. Listen in for details. 1. 2019: Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG; PITCHES study group. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet. 2019 Sep 7;394(10201):849-860. doi: 10.1016/S0140-6736(19)31270-X. Epub 2019 Aug 1. PMID: 31378395; PMCID: PMC6739598. https://pubmed.ncbi.nlm.nih.gov/31378395/2. February 08, 2025: Rahim, Mussarat N et al. Pregnancy and the liver. The Lancet. 2021; Volume 405, Issue 10477, 498 – 513 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02351-1/fulltext3. SMFM CS 53; 20214. Rosenberg, Henri M. MD; Sarker, Minhazur R. MD; Ramos, Gladys A. MD; Bianco, Angela MD; Ferrara, Lauren MD; DeBolt, Chelsea A. MD. Intrahepatic Cholestasis of Pregnancy Recurrence in a Subsequent Pregnancy. Obstetrics & Gynecology 147(2):p 239-241, February 2026. | DOI: 10.1097/AOG.0000000000006033 https://journals.lww.com/greenjournal/fulltext/2026/02000/intrahepatic_cholestasis_of_pregnancy_recurrence.13.aspx5. Ovadia C, Sajous J, Seed PT et al. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):547-558. doi: 10.1016/S2468-1253(21)00074-1. Epub 2021 Apr 27. PMID: 33915090; PMCID: PMC8192305.6. EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy. European Association for the Study of the Liver; 2023

In this episode in the Food as Medicine series, Dr. Parikh is joined by Dr. Gwenn Rosenberg Wildman who is clinical director at the New London Natural Health Center. They dive into the health perks of cabbage - a surprisingly powerful yet underappreciated ally for gut health.

On this Monday edition of Sid & Friends in the Morning, Sid focuses on New York City's political leadership addressing anti-Semitism, detailing the conflict between Mayor Mamdani and the City Council Speaker Julie Menin. Mamdani rescinded Adams-era policies related to anti-Semitism, while City Council Speaker Menin proposed new initiatives including increased funding for Holocaust education and security at religious institutions. Sid then covers a Miami Beach nightclub facing backlash for anti-Semitic content and a comment from Miami-Dade County Mayor Daniella Levine Cava regarding the incident. Rosenberg shifts to NYC's racial equity plan for New York City after Mayor Mamdani hired another problematic individual to lead the initiative, before he highlights more Bruce Springsteen remarks against President Trump during a surprise performance, today being Martin Luther King Jr. Day, increased security for tonight's College Football National Championship Game at Hard Rock Stadium in Miami due to President Trump's expected attendance, and finally discusses his alma mater Miami Hurricanes' potential in tonight's big game against Indiana. Bernie Kosar, Jacqueline Toboroff, John Catsimatidis, Leo Terrell & Phil Simms join Sid on this Monday installment of Sid & Friends in the Morning. Learn more about your ad choices. Visit megaphone.fm/adchoices

The MAJesty have a hilarious moment with Dip when he finally finds out the identity of the Americanos, then dive into why Jacob Fatu's return was perfectly executed. Peter gives his Royal Rumble picks, Dip cosigns a Drew McIntyre run, and the crew debates whether Sami Zayn's current character is championship-ready.Plus, new TNA World Champion Mike Santana taps in to discuss his title win, grief, overcoming addiction, and the possibility of a Royal Rumble appearance, and more.Listen to Cheap Heat Live Fridays 12pm- 2pm EST on Pro Wrestling Nation 24/7 on Channel 156.Call in at 844-344-4893Wanna stay MAJ?Join our PateronFollow @cheapheatpod on Instagram and TikTok @cheapheatpodsubscribe to Rosenberg's Youtube Channel.Email the show Rosenbergwrestling@gmail.com Hosted on Acast. See acast.com/privacy for more information.

On this Thursday edition of Sid & Friends in the Morning, Sid covers a variety of significant news topics, beginning with President Trump's threat to withhold federal funding from sanctuary cities like New York, highlighting the potential negative impacts on local organizations and city services. Rosenberg then details a controversy surrounding the NYC Token cryptocurrency, promoted by former Mayor Eric Adams, which faced accusations of a 'rug pull'. The Verizon service disruption is also discussed, affecting many users. Additionally, there's coverage of protests in Minneapolis following an ICE shooting incident, as well as updates on the US-Denmark talks over Greenland, with Trump pushing for US control to counter Russian and Chinese interests. Finally, Sid reports on John Harbaugh nearing an agreement to become the next head coach of the New York Giants. Bill O'Reilly, Jonny Daniels, Nicole Saphier, Riley Gaines & Ronn Torossian join Sid on this Friday-eve installment of Sid & Friends in the Morning. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this Wednesday Tunnel to Towers hump day edition of Sid & Friends in the Morning, Sid covers Governor Kathy Hochul's State of the State speech in New York, including her focus on affordability and opposing Donald Trump. Sid highlights her struggle against primary and Republican opponents, as well as her proposals for pocketbook issues and a buffer zone around places of worship. Thereafter, Rosenberg delves into New York City leaders' protest against ICE detention of an undocumented staff member and Trump's ongoing campaign against undocumented immigrants. Discussion then shifts to the Supreme Court case on banning trans athletes in girls' sports, with arguments for its necessity for fairness and safety. Lastly, Sid covers former President Clinton and Hillary Clinton's refusal to testify before a House committee on Jeffrey Epstein and President Trump's economic achievements and stern stance against Iran's crackdown on protests. Learn more about your ad choices. Visit megaphone.fm/adchoices

Listen in as I chat with return guest Jacob Rosenberg about his latest book, Epicenter. The photobook beautifully captures the skateboarding scene at the Embarcadero from 1990 to 1993. The accompanying IRL photo exhibit for Epicenter has been extended through Sunday, Jan. 25, at 201 Jackson St. More info here. Here's the last episode we did with Jake, all about his previous book, Right Before My Eyes: Jacob Rosenberg and the Bay Area Hip-Hop + Skateboarding Scenes of the Nineties We recorded this podcast over Zoom in December 2025. Photo of Jovantae Turner by Jacob Rosenberg

On this Monday edition of Sid & Friends in the Morning, Sid details the ongoing protests in Iran against the regime, emphasizing the government's harsh crackdown and President Trump's threats towards Iranian leaders, invoking U.S. actions in Venezuela and potential actions against Colombia and Mexican drug cartels. Sid then delves into statements from U.S. officials and exiled Iranian Crown Prince Reza Pahlavi regarding the mutiny. Finally, Rosenberg expands on crime concerns in New York before breaking down the Wild Card weekend that was in the first round of the NFL Playoffs. Alan Dershowitz, Bruce Blakeman, Donna Rotunno, Ellie Cohanim, John Catsimatidis & Jonny Daniels join Sid on this Monday installment of Sid & Friends in the Morning. Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textJamie Rosenberg is the Founder and Executive Chairman of ClassWallet, a fintech platform modernizing how public education funds are distributed to schools and families. A longtime social impact entrepreneur, he previously founded AdoptAClassroom.org and has spent over two decades focused on getting dollars closer to students.

The MAJesty break down why it's now impossible to imagine wrestling without Joe Tessitore, debate whether Rhea Ripley should move on from tag teams, and why she may need to embrace a heel turn when a split with IYO SKY finally happens. Plus, what WWE should really be doing with Oba Femi, and Rosenberg fires back at Dave Meltzer and Bryan Alvarez's takes on Seth Rollins' injury angle.Listen to Cheap Heat Live Fridays 12pm- 2pm EST on Pro Wrestling Nation 24/7 on Channel 156.Call in at 844-344-4893Wanna stay MAJ?Join our PateronFollow @cheapheatpod on Instagram and TikTok @cheapheatpodsubscribe to Rosenberg's Youtube Channel.Email the show Rosenbergwrestling@gmail.com Hosted on Acast. See acast.com/privacy for more information.

----- Check out e420 app for deals Apple: https://spn.so/g6gbid5j Google: https://spn.so/104g2yp6 use code NOJUMPER for $$ off Shout out to all our members who make this content possible, sign up for only $5 a month https://www.youtube.com/channel/UCNNTZgxNQuBrhbO0VrG8woA/join Promote Your Music with No Jumper - https://nojumper.com/pages/promo CHECK OUT OUR ONLINE STORE!!! https://nojumper.com NO JUMPER PATREON http://www.patreon.com/nojumper CHECK OUT OUR NEW SPOTIFY PLAYLIST https://open.spotify.com/playlist/5tesvmDS8h50LkjnSAWMOs?si=j6sJD6DkR4mk5NZZWnlK7g Follow us on SNAPCHAT https://www.snapchat.com/discover/No_Jumper/4874336901 Follow us on SPOTIFY: https://open.spotify.com/show/4z4yCTjwXa4an6sBGIe7m5 iTunes: https://itunes.apple.com/us/podcast/no-jumper/id1001659715?mt=2 Follow us on Social Media: https://www.snapchat.com/discover/No_Jumper/4874336901 http://www.twitter.com/nojumper http://www.instagram.com/nojumper https://www.facebook.com/nojumper http://www.reddit.com/r/nojumper JOIN THE DISCORD: https://discord.gg/Q3XPfBm Follow Adam22: http://www.instagram.com/adam22 adam22bro on Snapchat Learn more about your ad choices. Visit megaphone.fm/adchoices

On the first Cheap Heat of 2026, The MAJesty debates the most important question to start the year: when do you stop sending the “Happy New Year” text? Stat Guy Greg checks in from Hawaii, but Dip explains why paradise might be a little overrated.On the wrestling side, Rosenberg clashes with the sickos over the length of Jon Moxley's Worlds End promo and its match placement. They then debate whether Bron Breakker should take the World Heavyweight Title from CM Punk, what's next for The Usos as RAW Tag Team Champions, whether the Yeet Movement has finally run its course, and if there's a real vision for The Vision.Plus, Dip completely melts down after learning WWE's library has left Peacock, questioning what little joy he has left to watch on TV.Listen to Cheap Heat Live Fridays 12pm- 2pm EST on Pro Wrestling Nation 24/7 on Channel 156.Call in at 844-344-4893Wanna stay MAJ?Join our PateronFollow @cheapheatpod on Instagram and TikTok @cheapheatpodsubscribe to Rosenberg's Youtube Channel.Email the show Rosenbergwrestling@gmail.com Hosted on Acast. See acast.com/privacy for more information.

Most investors assume the only way to buy rental properties is through a traditional bank. Perfect W2 income. Clean tax returns. Endless paperwork. For anyone who is self employed, owns a business, or already investing, that system is broken. And it stops people from ever getting started. In this episode, Cory sits down with Jonathan Yoo and Dustin Rosenberg, co founders of Convoy Home Loans, to break down how everyday investors are buying and scaling rental properties without relying on traditional banks. They explain the lending tools most people never hear about, including DSCR loans and non bank financing options that focus on the property's income instead of your personal tax returns. We walk through how these loans actually work in plain English, who they are best for, and when they make sense for beginners versus experienced investors. Jonathan and Dustin also share what they are seeing across markets nationwide, why waiting for perfect interest rates can cost you years of progress, and how investors are using today's quieter market to buy smarter while others sit on the sidelines. This conversation also dives into partnership, building a business alongside investing, and why understanding financing early gives you a massive advantage long term. If you are trying to buy your first rental, scale past a few properties, or feel stuck because banks keep saying no, this episode will show you a simpler path forward and help you rethink what is actually possible.This is not about gaming the system. It is about learning how the system really works so you can use it with confidence. Book your call with Neo Home Loanshttps://www.neoentrepreneurhomeloans.com/wealthjuice/ Book your mentorship discovery call with Cory RESOURCES

Learn more about your ad choices. Visit megaphone.fm/adchoices

The MAJesty breaks down John Cena's send-off, the fan backlash, and what it all means for Gunther moving forward. We also react to Austin Theory being revealed as the masked man, what's next for him, and why this version of Nikki Bella is truly MAJ.Then things take a hard left into bougie crackers, cheeses, cured meats, and jams, before closing out with Big Toilet Talk, including whether bidets are actually worth installing.Listen to Cheap Heat Live Fridays 12pm- 2pm EST on Pro Wrestling Nation 24/7 on Channel 156.Call in at 844-344-4893Wanna stay MAJ?Join our PateronFollow @cheapheatpod on Instagram and TikTok @cheapheatpodsubscribe to Rosenberg's Youtube Channel.Email the show Rosenbergwrestling@gmail.com Hosted on Acast. See acast.com/privacy for more information.

Ebro, Laura, and Rosenberg host HOT 97's flagship program "Ebro In The Morning!" on today's episode 12/12/25 - Michigan Football Coach Arrest, Rakim for the Rock N Roll Hall of Fame, New Nas, DJ John’s Christmas Suspension, Freedom Friday and much more! All that and more on Ebro In The Morning! To be a part of the Gurus email theguru@ebrointhemorning.com To be a part of Freedom Friday email info@ebrointhemorning.comSee omnystudio.com/listener for privacy information.